{"downloaded": true, "htmlmade": false, "full": {"id": "34113555", "source": "MED", "pmid": "34113555", "pmcid": "PMC8185331", "fullTextIdList": {"fullTextId": "PMC8185331"}, "doi": "10.3389/fonc.2021.596342", "title": "Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report.", "authorString": "He Y, Wang L, Li X, Zhang T, Song T, Zhang J, Yu Y, Chen S, Song H.", "authorList": {"author": [{"fullName": "He Y", "firstName": "Yanxin", "lastName": "He", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Internal Medicine-Oncology, Qingdao Tumor Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China."}}}, {"fullName": "Wang L", "firstName": "Lunqing", "lastName": "Wang", "initials": "L", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Thoracic Surgery, Qingdao Municipal Hospital, Qingdao, China."}}}, {"fullName": "Li X", "firstName": "Xiao", "lastName": "Li", "initials": "X", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Internal Medicine-Oncology, Qingdao Tumor Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China."}}}, {"fullName": "Zhang T", "firstName": "Tongsong", "lastName": "Zhang", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Internal Medicine-Oncology, Qingdao Tumor Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China."}}}, {"fullName": "Song T", "firstName": "Tingting", "lastName": "Song", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Internal Medicine-Oncology, Qingdao Tumor Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China."}}}, {"fullName": "Zhang J", "firstName": "Junling", "lastName": "Zhang", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Medical Department, 3D Medicines Inc., Shanghai, China."}}}, {"fullName": "Yu Y", "firstName": "Yangyang", "lastName": "Yu", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Medical Department, 3D Medicines Inc., Shanghai, China."}}}, {"fullName": "Chen S", "firstName": "Shiqing", "lastName": "Chen", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "The Medical Department, 3D Medicines Inc., Shanghai, China."}}}, {"fullName": "Song H", "firstName": "Haiping", "lastName": "Song", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Internal Medicine-Oncology, Qingdao Tumor Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China."}}}]}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"volume": "11", "journalIssueId": "3115901", "dateOfPublication": "2021", "monthOfPublication": "0", "yearOfPublication": "2021", "printPublicationDate": "2021-01-01", "journal": {"title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol", "medlineAbbreviation": "Front Oncol", "NLMid": "101568867", "ISSN": "2234-943X", "ESSN": "2234-943X"}}, "pubYear": "2021", "pageInfo": "596342", "abstractText": "Colorectal squamous cell carcinoma (SCC) is extremely rare and associated with a poor prognosis. And the pMMR/MSS colorectal cancer is related to a limited response to programmed death ligand-1 (PD-1) blockade monotherapy. However, the clinical activity of PD-1 blockade monotherapy or combination therapy in colorectal SCC is unknown. One patient with rectosigmoid-junction SCC was treated with PD-1 blockade combined with chemotherapy. After 3 months of PD-1 blockade and chemotherapy, the computed tomography imaging showed that this patient achieved a partial response. The next generation sequencing and immunohistochemistry analysis showed that the patient had tumors with proficient mismatch repair (pMMR) and microsatellite stability (MSS), strong PD-L1 expression, and tumor mutational burden-high (TMB-High), respectively. This case suggests that PD-1 blockade combined with chemotherapy might be an effective therapy for colorectal SCC with pMMR/MSS status. Moreover, the PD-L1 expression and TMB might be the potential predictors of PD-1 blockade response for colorectal SCC patients.", "affiliation": "Department of Internal Medicine-Oncology, Qingdao Tumor Hospital, The Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, China.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic-eCollection", "pubTypeList": {"pubType": ["Case Reports", "case-report"]}, "keywordList": {"keyword": ["Tumor Mutation Burden", "Programmed Death Ligand-1 Blockade", "Programmed Death Ligand-1 Expression", "Proficient Mismatch Repair/Microsatellite Stability", "Rectosigmoid-Junction Squamous Cell Carcinoma"]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3389/fonc.2021.596342"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC8185331"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC8185331?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCreation": "2021-06-11", "firstIndexDate": "2021-06-12", "fullTextReceivedDate": "2021-06-10", "dateOfRevision": "2021-06-12", "electronicPublicationDate": "2021-05-25", "firstPublicationDate": "2021-05-25"}, "htmllinks": "https://europepmc.org/articles/PMC8185331", "abstract": "Colorectal squamous cell carcinoma (SCC) is extremely rare and associated with a poor prognosis. And the pMMR/MSS colorectal cancer is related to a limited response to programmed death ligand-1 (PD-1) blockade monotherapy. However, the clinical activity of PD-1 blockade monotherapy or combination therapy in colorectal SCC is unknown. One patient with rectosigmoid-junction SCC was treated with PD-1 blockade combined with chemotherapy. After 3 months of PD-1 blockade and chemotherapy, the computed tomography imaging showed that this patient achieved a partial response. The next generation sequencing and immunohistochemistry analysis showed that the patient had tumors with proficient mismatch repair (pMMR) and microsatellite stability (MSS), strong PD-L1 expression, and tumor mutational burden-high (TMB-High), respectively. This case suggests that PD-1 blockade combined with chemotherapy might be an effective therapy for colorectal SCC with pMMR/MSS status. Moreover, the PD-L1 expression and TMB might be the potential predictors of PD-1 blockade response for colorectal SCC patients.", "Keywords": ["Tumor Mutation Burden", "Programmed Death Ligand-1 Blockade", "Programmed Death Ligand-1 Expression", "Proficient Mismatch Repair/Microsatellite Stability", "Rectosigmoid-Junction Squamous Cell Carcinoma"], "pdflinks": "https://europepmc.org/articles/PMC8185331?pdf=render", "journaltitle": "Frontiers in oncology", "authorinfo": ["He Y", "Wang L", "Li X", "Zhang T", "Song T", "Zhang J", "Yu Y", "Chen S", "Song H"], "title": "Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report."}